3,147 reports of this reaction
2.9% of all ETONOGESTREL reports
#11 most reported adverse reaction
PREGNANCY WITH IMPLANT CONTRACEPTIVE is the #11 most commonly reported adverse reaction for ETONOGESTREL, manufactured by Organon LLC. There are 3,147 FDA adverse event reports linking ETONOGESTREL to PREGNANCY WITH IMPLANT CONTRACEPTIVE. This represents approximately 2.9% of all 110,074 adverse event reports for this drug.
Patients taking ETONOGESTREL who experience pregnancy with implant contraceptive should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PREGNANCY WITH IMPLANT CONTRACEPTIVE is a less commonly reported adverse event for ETONOGESTREL, but still significant enough to appear in the safety profile.
In addition to pregnancy with implant contraceptive, the following adverse reactions have been reported for ETONOGESTREL:
PREGNANCY WITH IMPLANT CONTRACEPTIVE has been reported as an adverse event in 3,147 FDA reports for ETONOGESTREL. This does not prove causation, but indicates an association observed in post-market surveillance data.
PREGNANCY WITH IMPLANT CONTRACEPTIVE accounts for approximately 2.9% of all adverse event reports for ETONOGESTREL, making it a notable side effect.
If you experience pregnancy with implant contraceptive while taking ETONOGESTREL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.